 | Replimune Group, Inc. | |||
| NMS : REPL || Location: United States | ||||
$6.49+0.34 (+5.53%) |
0.19 M | 6.06 - 6.57 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 8.341 M |
| March 28, 2024 | 7.737 M |
| March 15, 2024 | 6.924 M |
| Feb. 29, 2024 | 6.480 M |
| Feb. 15, 2024 | 6.145 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.95 | -0.77 | 18.62% |
| 09/30/2023 | -0.87 | -0.90 | -3.12% |
| 06/30/2023 | -0.86 | -0.75 | 12.88% |
| 03/31/2023 | -0.69 | -0.74 | -7.68% |
| 12/31/2022 | -0.77 | -0.69 | 10.33% |
REPL Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 61.388M | Shares Float | 39.050M |
| Short Float | 8.341M | Market Cap | 377.54M |
| Institution ownership | 0.00% | Insider ownership | 5.797% |
| Earnings Date | 05/16/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -3.16 | Forward EPS | -3.03 |